Cargando…

Comment on: Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis

Detalles Bibliográficos
Autores principales:	Yin, Cong, Li, Juan, Yuan, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10189067/ https://www.ncbi.nlm.nih.gov/pubmed/36864618 http://dx.doi.org/10.1002/clc.23994

Ejemplares similares

Benefits of tolvaptan on early dyspnea relief in patients with acute heart failure: A meta‐analysis
por: Shang, Wenli, et al.
Publicado: (2022)

Clevidipine-induced Dyspnea Relief in Acute Heart Failure Patients
por: Stoicea, Nicoleta, et al.
Publicado: (2016)

Tolvaptan, hyponatremia, and heart failure
por: Zmily, Hammam D, et al.
Publicado: (2011)

The management of polycystic liver disease by tolvaptan
por: Takenaka, Tsuneo, et al.
Publicado: (2020)

Renoprotective Benefit of Tolvaptan in Acute Decompensated Heart Failure Patients With Loop Diuretic-Resistant Status
por: Yamamoto, Tomohiko, et al.
Publicado: (2019)

Early Initiation of Tolvaptan is Associated with Early Discharge in Elderly Heart Failure Patients
por: Kiuchi, Shunsuke, et al.
Publicado: (2021)

Sex differences in early dyspnea relief between men and women hospitalized for acute heart failure: insights from the RELAX-AHF study
por: Meyer, Sven, et al.
Publicado: (2016)

Benefit of tolvaptan in the management of hyponatraemia in patients with diuretic‐refractory congestive heart failure: the SEMI‐SEC project
por: Pose, Antonio, et al.
Publicado: (2017)

Comment on: Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: Rationale and design of SHIFT‐AHF trial
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Hemodynamic and Hormonal Effects of Tolvaptan for Heart Failure
por: Kiuchi, Shunsuke, et al.
Publicado: (2018)

Early treatment with tolvaptan improves diuretic response in acute heart failure with renal dysfunction
por: Matsue, Yuya, et al.
Publicado: (2017)

Prognostic Impact of the Early Use of Tolvaptan in Elderly Patients with Acute Decompensated Heart Failure
por: Okada, Tomoaki, et al.
Publicado: (2023)

Effects of Tolvaptan in patients with acute heart failure: a systematic review and meta-analysis
por: Wang, Chunbin, et al.
Publicado: (2017)

Tolvaptan in reversing worsening acute heart failure: A systematic review and meta-analysis
por: Wang, Lili, et al.
Publicado: (2019)

Tolvaptan should be used very carefully in very elderly patients
por: Kahraman, Fatih, et al.
Publicado: (2018)

Therapy with the Combination of Tolvaptan and Furosemide for Refractory Edema in Nephrotic Syndrome
por: Meena, Jitendra, et al.
Publicado: (2020)

Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients
por: Bargagli, Matteo, et al.
Publicado: (2021)

Early initiation of tolvaptan is associated with early discharge in patients with heart failure regardless of age
por: Kiuchi, Shunsuke, et al.
Publicado: (2022)

Cough to Dyspnea to Acute Respiratory Distress Syndrome
por: Jiwani, Rahim A., et al.
Publicado: (2021)

Tolvaptan: A Novel Diuretic in Heart Failure Management
por: Zulkifli Amin, Hilman, et al.
Publicado: (2016)

Long-Term Tolvaptan Treatment in Refractory Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2019)

Clinical utility of early use of tolvaptan in very elderly patients with acute decompensated heart failure
por: Niikura, Hiroki, et al.
Publicado: (2017)

Tolvaptan add‐on therapy in patients with acute heart failure: A systematic review and meta‐analysis
por: Luo, Xiandu, et al.
Publicado: (2020)

Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome
por: Aghel, Arash, et al.
Publicado: (2008)

Renoprotective effect of tolvaptan in patients with new‐onset acute heart failure
por: Kin, Hiromi, et al.
Publicado: (2020)

Comment on: The Benefits of Resistance Training in Obese Adolescents: A Systematic Review and Meta-analysis
por: Zhang, Fan
Publicado: (2023)

Optimal Patient Selection and Treatment Timing for Tolvaptan Therapy Following Cardiovascular Surgery
por: Horie, Kotaro, et al.
Publicado: (2023)

Comments on “The Relationship between Symptom Relief and Psychosocial Functional Improvement during Acute Electroconvulsive Therapy for Patients with Major Depressive Disorder”
por: McCall, W Vaughn, et al.
Publicado: (2017)

Scale of dyspnea in COPD: User friendly?
por: Wiwanitkit, Viroj
Publicado: (2010)

Comment on: Factors affecting the early and mid-term success of needling for early failure of filtering bleb
por: Singla, Ekta, et al.
Publicado: (2021)

Reply to Comments on Relationship between Hypoalbuminemia on Admission and Long-term Mortality in Patients with Acute Decompensated Heart Failure
por: Yatsu, Shoichiro, et al.
Publicado: (2019)

Effects of tolvaptan add-on therapy in patients with acute heart failure: meta-analysis on randomised controlled trials
por: Ma, Guang, et al.
Publicado: (2019)

Effects of exertional dyspnea on early mobilization of patients with acute decompensated heart failure
por: Yamazaki, Yota, et al.
Publicado: (2022)

Clinical utility of tolvaptan in the management of hyponatremia in heart failure patients
por: Nodari, Savina, et al.
Publicado: (2010)

Tolvaptan for water retention in heart failure: a systematic review
por: Pan, Yujing, et al.
Publicado: (2023)

Comment on “Physical Exercise and Patients with Chronic Renal Failure: A Meta-Analysis”
por: Alwardat, Mohammad
Publicado: (2018)

Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”
por: Heida, Judith E., et al.
Publicado: (2021)

Response to comment on: Factors affecting the early and mid-term success of needling for early failure of filtering bleb
por: Demirok, Gülizar, et al.
Publicado: (2021)

Comments on “Nebulised fentanyl for post operative pain relief, a prospective double blind controlled randomised clinical trial”
por: Mather, Laurence E
Publicado: (2014)

Response to comments: Nebulised fentanyl for post-operative pain relief, a prospective double-blind controlled randomised clinical trial
por: Singh, Anil P, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_miv2fq247nrnb1217e72av30m4